Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jacobio Pharmaceuticals Group Co., Ltd. ( (HK:1167) ) just unveiled an announcement.
Jacobio Pharmaceuticals Group Co., Ltd. has announced changes in shareholdings among its Concert Parties, with a significant purchase of 11,058,650 shares, reflecting strong confidence in the company’s growth potential and long-term investment value. Additionally, the company has been actively repurchasing its shares on the market, with a total of 326,400 shares bought back, as part of a larger HK$100 million share repurchase plan, indicating the board’s belief that the current share price undervalues the company’s intrinsic worth.
The most recent analyst rating on (HK:1167) stock is a Hold with a HK$5.30 price target. To see the full list of analyst forecasts on Jacobio Pharmaceuticals Group Co., Ltd. stock, see the HK:1167 Stock Forecast page.
More about Jacobio Pharmaceuticals Group Co., Ltd.
Jacobio Pharmaceuticals Group Co., Ltd. is a company in the pharmaceutical industry, focusing on the development of innovative drugs. Its core product pipeline includes promising treatments such as the Pan-KRAS inhibitor, and it is committed to advancing research and development in this field.
Average Trading Volume: 9,369,289
Technical Sentiment Signal: Buy
Current Market Cap: HK$7.49B
For an in-depth examination of 1167 stock, go to TipRanks’ Overview page.